Cargando…
Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists
Knockout mice studies implicate the mammalian short-chain fatty acid (SCFA) receptors, FFAR2 and FFAR3– in colitis, arthritis and asthma. However, the correlation with human biology is uncertain. Here, we detected FFAR2 and FFAR3 expression in human monocytes via immunohistochemistry. Upon treatment...
Autores principales: | Ang, Zhiwei, Er, Jun Zhi, Tan, Nguan Soon, Lu, Jinhua, Liou, Yih-Cherng, Grosse, Johannes, Ding, Jeak Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036191/ https://www.ncbi.nlm.nih.gov/pubmed/27667443 http://dx.doi.org/10.1038/srep34145 |
Ejemplares similares
-
FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing
por: Ang, Zhiwei, et al.
Publicado: (2018) -
Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
por: Fabisiak, Adam, et al.
Publicado: (2020) -
Molecular characterization of free fatty acid receptors FFAR2 and FFAR3 in the domestic cat
por: Yamamoto, Ichiro, et al.
Publicado: (2020) -
Optimization
of First-in-Class Dual-Acting FFAR1/FFAR4
Allosteric Modulators with Novel Mode of Action
por: Lückmann, Michael, et al.
Publicado: (2022) -
Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine
por: Pon`kina, Darya, et al.
Publicado: (2023)